BRPI0517467A - ácidos carboxìlicos (bifenila) e derivados destes - Google Patents
ácidos carboxìlicos (bifenila) e derivados destesInfo
- Publication number
- BRPI0517467A BRPI0517467A BRPI0517467-8A BRPI0517467A BRPI0517467A BR PI0517467 A BRPI0517467 A BR PI0517467A BR PI0517467 A BRPI0517467 A BR PI0517467A BR PI0517467 A BRPI0517467 A BR PI0517467A
- Authority
- BR
- Brazil
- Prior art keywords
- biphenyl
- derivatives
- carboxylic acids
- compounds
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D309/06—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
CIDOS CARBOXìLICOS (BIFENILA) E DERIVADOS DESTES. A presente invenção refere-se a compostos que têm a fórmula geral (1) com as definições de A, X, R~ 1~-R~ 6~ dadas abaixo, e/ou um sal ou éster destes. Além disso, a invenção refere-se ao uso dos referidos compostos para o tratamento de doença de Alzheimer e seu uso para a modulação de atividade de <sym>-secretase.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04025003 | 2004-10-21 | ||
EP04026125A EP1650183A1 (en) | 2004-10-21 | 2004-11-04 | (Benzyloxy-biphenyl) acetic acids and derivatives thereof and their use in therapy |
US64210005P | 2005-01-10 | 2005-01-10 | |
PCT/EP2005/011349 WO2006045554A1 (en) | 2004-10-21 | 2005-10-21 | (biphenyl) carboxylic acids and derivatives thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0517467A true BRPI0517467A (pt) | 2008-10-07 |
Family
ID=34927231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0517467-8A BRPI0517467A (pt) | 2004-10-21 | 2005-10-21 | ácidos carboxìlicos (bifenila) e derivados destes |
Country Status (29)
Country | Link |
---|---|
US (1) | US7825160B2 (pt) |
EP (2) | EP1650183A1 (pt) |
JP (1) | JP5054532B2 (pt) |
KR (1) | KR101326358B1 (pt) |
CN (1) | CN101084178B (pt) |
AP (1) | AP2007003978A0 (pt) |
AT (1) | ATE425952T1 (pt) |
AU (1) | AU2005298880B2 (pt) |
BR (1) | BRPI0517467A (pt) |
CA (1) | CA2584664C (pt) |
DE (1) | DE602005013417D1 (pt) |
DK (1) | DK1805129T3 (pt) |
EA (1) | EA012417B1 (pt) |
ES (1) | ES2324307T3 (pt) |
GE (1) | GEP20105082B (pt) |
HR (1) | HRP20090316T1 (pt) |
IL (1) | IL182712A (pt) |
MA (1) | MA29514B1 (pt) |
MX (1) | MX2007004763A (pt) |
NI (1) | NI200700107A (pt) |
NO (1) | NO20072153L (pt) |
NZ (1) | NZ554724A (pt) |
PL (1) | PL1805129T3 (pt) |
PT (1) | PT1805129E (pt) |
RS (1) | RS50818B (pt) |
SI (1) | SI1805129T1 (pt) |
SM (1) | SMP200700016B (pt) |
TN (1) | TNSN07148A1 (pt) |
WO (1) | WO2006045554A1 (pt) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006126514A1 (ja) * | 2005-05-27 | 2006-11-30 | Shionogi & Co., Ltd. | イソキサゾール骨格を有するアリール酢酸誘導体 |
CN101809019A (zh) | 2007-05-07 | 2010-08-18 | 先灵公司 | γ分泌酶调节剂 |
MX2009013130A (es) | 2007-06-01 | 2010-01-15 | Schering Corp | Moduladores de gamma secretasa. |
EP2152695A2 (en) | 2007-06-01 | 2010-02-17 | Schering Corporation | Gamma secretase modulators |
CA2692253A1 (en) * | 2007-06-29 | 2009-01-08 | Schering Corporation | Gamma secretase modulators |
JP2010538068A (ja) | 2007-09-06 | 2010-12-09 | シェーリング コーポレイション | ガンマセクレターゼモジュレーター |
CN101861297B (zh) * | 2007-10-17 | 2014-04-23 | 詹森药业有限公司 | 联苯羧酸及其衍生物 |
ES2378594T3 (es) * | 2007-10-19 | 2012-04-16 | Janssen Pharmaceutica, N.V. | Moduladores de piperidinilo y piperazinilo de la y-secretasa |
EP2212277B1 (en) * | 2007-10-19 | 2016-08-31 | Janssen Pharmaceutica, N.V. | Amine linked modulators of y-secretase |
US20090306392A1 (en) * | 2007-10-19 | 2009-12-10 | Chih Yung Ho | Gsm intermediates |
CN101896452B (zh) * | 2007-10-19 | 2013-07-31 | 詹森药业有限公司 | 连接有碳的γ-分泌酶调节剂 |
EA017907B1 (ru) * | 2007-10-19 | 2013-04-30 | Янссен Фармацевтика Н.В. | МОДУЛЯТОРЫ γ-СЕКРЕТАЗЫ С АМИДНЫМИ СВЯЗЯМИ |
MX2010005028A (es) | 2007-11-05 | 2010-05-27 | Schering Corp | Moduladores de gamma secretasa. |
US20110092554A1 (en) * | 2007-11-19 | 2011-04-21 | Richard Chesworth | 1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders |
WO2009073777A1 (en) | 2007-12-06 | 2009-06-11 | Schering Corporation | Gamma secretase modulators |
JP2011506461A (ja) | 2007-12-11 | 2011-03-03 | シェーリング コーポレイション | γ−セクレターゼモジュレーター |
US8217064B2 (en) * | 2007-12-20 | 2012-07-10 | Envivo Pharmaceuticals, Inc. | Tetrasubstituted benzenes |
EP2133322A1 (en) * | 2008-06-11 | 2009-12-16 | CHIESI FARMACEUTICI S.p.A. | Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid |
AU2009314205A1 (en) | 2008-11-13 | 2010-05-20 | Merck Sharp & Dohme Corp. | Gamma secretase modulators |
AU2009314049B2 (en) | 2008-11-13 | 2015-03-05 | Merck Sharp & Dohme Corp. | Gamma secretase modulators |
CA2747744A1 (en) | 2008-12-22 | 2010-07-01 | Theodros Asberom | Gamma secretase modulators |
EP2379566A2 (en) | 2008-12-22 | 2011-10-26 | Schering Corporation | Gamma secretase modulators |
US20120232108A1 (en) | 2009-06-16 | 2012-09-13 | Xianhai Huang | Gamma secretase modulators |
WO2010147969A2 (en) | 2009-06-16 | 2010-12-23 | Schering Corporation | Gamma secretase modulators |
WO2010147975A1 (en) | 2009-06-16 | 2010-12-23 | Schering Corporation | Gamma secretase modulators |
US20120129189A1 (en) * | 2009-07-17 | 2012-05-24 | Chulan Kwon | Methods of Controlling Cell Proliferation |
KR101737653B1 (ko) * | 2009-08-04 | 2017-05-18 | 키에시 파르마슈티시 엣스. 피. 에이. | 1-(2-할로비페닐-4-일)-시클로프로판카복실산 유도체의 제조 방법 |
ES2668422T3 (es) | 2012-04-20 | 2018-05-18 | Gilead Sciences, Inc. | Derivados del ácido benzotiazol-6-il acético y su uso para tratar una infección por VIH |
CN104045552B (zh) * | 2013-03-13 | 2019-06-11 | 江苏先声药业有限公司 | 作为神经保护剂的药用化合物 |
WO2016201168A1 (en) | 2015-06-10 | 2016-12-15 | Forum Pharmceuticals Inc. | Oxadiazine compounds and methods of use thereof |
CA3109419A1 (en) * | 2018-08-24 | 2020-02-27 | Xeniopro GmbH | Novel compounds |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2406383A1 (en) * | 2000-04-13 | 2001-10-25 | Mayo Foundation For Medical Education And Research | A.beta.42 lowering agents |
CN1585638A (zh) * | 2001-09-14 | 2005-02-23 | 图拉里克公司 | 被连接的联芳基化合物 |
WO2004064771A2 (en) * | 2003-01-14 | 2004-08-05 | Merck & Co., Inc. | Geminally di-substituted nsaid derivatives as abeta 42 lowering agents |
ITMI20030312A1 (it) * | 2003-02-21 | 2004-08-22 | Chiesi Farma Spa | Derivati di acidi 2-fenil-2-alchil-acetici per il trattamento della malattia di alzheimer. |
GB0416508D0 (en) * | 2004-07-23 | 2004-08-25 | Merck Sharp & Dohme | Therapeutic agents |
EP1657232A1 (en) * | 2004-11-05 | 2006-05-17 | Cellzome Ag | Use of S-enantiomers of alpha-sustituted aryl acetic acids for the prevention of Alzheimer's disease |
-
2004
- 2004-11-04 EP EP04026125A patent/EP1650183A1/en not_active Withdrawn
-
2005
- 2005-10-21 ES ES05799330T patent/ES2324307T3/es active Active
- 2005-10-21 PT PT05799330T patent/PT1805129E/pt unknown
- 2005-10-21 SM SM200700016T patent/SMP200700016B/it unknown
- 2005-10-21 GE GEAP200510076A patent/GEP20105082B/en unknown
- 2005-10-21 SI SI200530663T patent/SI1805129T1/sl unknown
- 2005-10-21 MX MX2007004763A patent/MX2007004763A/es active IP Right Grant
- 2005-10-21 CN CN2005800436804A patent/CN101084178B/zh not_active Expired - Fee Related
- 2005-10-21 RS RSP-2009/0243A patent/RS50818B/sr unknown
- 2005-10-21 PL PL05799330T patent/PL1805129T3/pl unknown
- 2005-10-21 EA EA200700860A patent/EA012417B1/ru not_active IP Right Cessation
- 2005-10-21 AT AT05799330T patent/ATE425952T1/de active
- 2005-10-21 AP AP2007003978A patent/AP2007003978A0/xx unknown
- 2005-10-21 CA CA2584664A patent/CA2584664C/en not_active Expired - Fee Related
- 2005-10-21 EP EP05799330A patent/EP1805129B1/en active Active
- 2005-10-21 DE DE602005013417T patent/DE602005013417D1/de active Active
- 2005-10-21 KR KR1020077009097A patent/KR101326358B1/ko not_active IP Right Cessation
- 2005-10-21 WO PCT/EP2005/011349 patent/WO2006045554A1/en active Application Filing
- 2005-10-21 US US11/665,760 patent/US7825160B2/en not_active Expired - Fee Related
- 2005-10-21 DK DK05799330T patent/DK1805129T3/da active
- 2005-10-21 AU AU2005298880A patent/AU2005298880B2/en not_active Ceased
- 2005-10-21 JP JP2007537225A patent/JP5054532B2/ja not_active Expired - Fee Related
- 2005-10-21 NZ NZ554724A patent/NZ554724A/en not_active IP Right Cessation
- 2005-10-21 BR BRPI0517467-8A patent/BRPI0517467A/pt not_active IP Right Cessation
-
2007
- 2007-04-19 TN TNP2007000148A patent/TNSN07148A1/fr unknown
- 2007-04-20 NI NI200700107A patent/NI200700107A/es unknown
- 2007-04-22 IL IL182712A patent/IL182712A/en not_active IP Right Cessation
- 2007-04-25 NO NO20072153A patent/NO20072153L/no not_active Application Discontinuation
- 2007-05-17 MA MA29911A patent/MA29514B1/fr unknown
-
2009
- 2009-05-29 HR HR20090316T patent/HRP20090316T1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0517467A (pt) | ácidos carboxìlicos (bifenila) e derivados destes | |
AR060568A1 (es) | Acidos bifenilcarboxilicos substituidos y sus derivados | |
EA200800303A1 (ru) | Применение производных и аналогов тиазола при нарушениях, вызванных свободными жирными кислотами | |
CR10376A (es) | Derivados de terfenil para el tratamiento de la enfermedad de alzheimer | |
BRPI0410037A (pt) | inibidores da fosfatidilinositol 3-cinase | |
BR0211122A (pt) | Composto, métodos para o tratamento ou prevenção de doenças e para fabricar um composto, intermediário, e, uso de um composto ou sal | |
BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
BRPI0513750A (pt) | 2-fenilamino-benzamidas-5-substituìdas como inibidoras de mek | |
CY1111170T1 (el) | Ενωσεις διαρυλ αιθερα ουριας | |
DOP2010000408A (es) | Compuestos quimicos 251 | |
BR112012011072A2 (pt) | inibidores de n1-pirazolospirocetona acetil-coa carboxilase | |
BRPI0710485B8 (pt) | composições líquidas úteis no tratamento de doenças respiratórias | |
BRPI0514448A (pt) | derivados do ácido bifenil-oxiacético para uso no tratamento de doenças respiratórias | |
BRPI0913291A2 (pt) | composto, pró-droga, medicamento, métodos para diminuir a proteína 4 ou tratamento de diabete em um mamífero, e, uso do composto | |
BRPI0706992C8 (pt) | composto de fórmula (i) e formulação farmacêutica | |
BRPI0512954A (pt) | ácidos graxos de cadeia média aplicáveis como agentes antimicrobianos | |
BRPI0412130A (pt) | compostos tetracìclicos como inibidores de c-met | |
ATE486852T1 (de) | Salze von 9-oxoacridin-10-essigsäure mit 1- alkylamino-1-desoxypolyolen | |
BR9916807A (pt) | Antagonistas de 5ht1 para terapia antidepressiva | |
BRPI0411087A (pt) | aperfeiçoamentos em ou relacionados a compostos orgánicos | |
CO6270313A2 (es) | Acidos carboxilicos bifenil y derivados de los mismos | |
BR0312385A (pt) | Preparação, processos para produzir a mesma e uma ração contendo diformiato e/ou aditivo de ração, uso de uma preparação, e, ração animal | |
EA201070496A1 (ru) | УГЛЕРОД-СВЯЗАННЫЕ МОДУЛЯТОРЫ γ-СЕКРЕТАЗЫ | |
EA201070494A1 (ru) | МОДУЛЯТОРЫ γ-СЕКРЕТАЗЫ С АМИДНЫМИ СВЯЗЯМИ | |
BR0311955A (pt) | Derivados de ftalamida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: CELLZOME LIMITED (GB) Free format text: TRANSFERIDO DE: CELLZOME AG. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014. |